A girl having congenital chloride diarrhea treated with spironolactone for seven years.
We report on a girl having congenital chloride diarrhea (CCD) who has been followed for 7 years and 6 months sequentially. Dilated intestinal loops, marked enlargement of the abdominal circumference of the fetus and hydramnios were noted by ultrasound examination at 31 weeks of gestation. After delivery by cesarean section for hydramnios, she excreted profuse watery yellow green stools with marked abdominal distension. At 4 months of age, hypochloremia, hyponatremia and a high concentration of chloride in the stool were identified. She was diagnosed as having CCD. Because it was difficult to administer a large volume of potassium chloride (KCl), and sodium chloride (NaCl), we decided to administer spironolactone. After administration of spironolactone, we could generate correct serum electrolytes using less amounts of KCl. At 7 years and 6 months of age, her body size was within normal limits and her intellectual, mental and physical development had been normal. In spite of normal serum electrolytes, blood pH and the presence of chloriduria, secondary hyperaldosteronism was noted. We consider that spironolactone may be useful to decrease the amount of KCl administration in the neonatal period, but frequent measurements of renin, angiotensin and aldosterone would be necessary for adequate control in CCD cases.
Asano
T
T
Department of Pediatrics, National Tosei Hospital, Shizuoka, Japan.
Maruyama
K
K
Jinbo
O
O
Tsumura
H
H
Furuya
F
F
Morita
T
T
Hirayama
T
T
D002648:Child; D002712:Chlorides / Q000378:metabolism*; D003967:Diarrhea / Q000151:congenital* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D013148:Spironolactone / Q000627:therapeutic use*
D002712:Chlorides; D013148:Spironolactone